Leibel S - Search Results

1

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer.

Kattan MW, Potters L, Blasko JC, Beyer DC, Fearn P, Cavanagh W, Leibel S, Scardino PT. Kattan MW, et al. Among authors: leibel s. Urology. 2001 Sep;58(3):393-9. doi: 10.1016/s0090-4295(01)01233-x. Urology. 2001. PMID: 11549487

2

The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy.

Potters L, Purrazzella R, Brustein S, Fearn P, Huang D, Leibel SA, Kattan MW. Potters L, et al. Among authors: leibel sa. Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):749-54. doi: 10.1016/s0360-3016(03)00009-9. Int J Radiat Oncol Biol Phys. 2003. PMID: 12788181

3

Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.

Kattan MW, Zelefsky MJ, Kupelian PA, Cho D, Scardino PT, Fuks Z, Leibel SA. Kattan MW, et al. J Clin Oncol. 2003 Dec 15;21(24):4568-71. doi: 10.1200/JCO.2003.05.046. J Clin Oncol. 2003. PMID: 14673043

4

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.

Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, Slawin KM. Stephenson AJ, et al. Among authors: leibel sa. JAMA. 2004 Mar 17;291(11):1325-32. doi: 10.1001/jama.291.11.1325. JAMA. 2004. PMID: 15026399

5

A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.

Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW. Potters L, et al. Among authors: leibel sa. Cancer. 2002 Oct 1;95(7):1451-6. doi: 10.1002/cncr.10869. Cancer. 2002. PMID: 12237913 Free article.

6

Isotope selection for patients undergoing prostate brachytherapy.

Cha CM, Potters L, Ashley R, Freeman K, Wang XH, Waldbaum R, Leibel S. Cha CM, et al. Among authors: leibel s. Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):391-5. doi: 10.1016/s0360-3016(99)00187-x. Int J Radiat Oncol Biol Phys. 1999. PMID: 10487561

7

Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.

Potters L, Cha C, Oshinsky G, Venkatraman E, Zelefsky M, Leibel S. Potters L, et al. Among authors: leibel s. Cancer J Sci Am. 1999 Sep-Oct;5(5):301-6. Cancer J Sci Am. 1999. PMID: 10526671

8

Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria.

Potters L, Perez CA, Beyer DC, Blasko JC, Forman JD, Hussey DH, Lee WR, Paryani SB, Pollack A, Roach M 3rd, Scardino P, Schellhammer P, Leibel S. Potters L, et al. Among authors: leibel s. Radiology. 2000 Jun;215 Suppl:1383-400. Radiology. 2000. PMID: 11037554 No abstract available.

9

The definition of biochemical failure in patients treated with definitive radiotherapy.

Kattan MW, Fearn PA, Leibel S, Potters L. Kattan MW, et al. Among authors: leibel s. Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1469-74. doi: 10.1016/s0360-3016(00)01359-6. Int J Radiat Oncol Biol Phys. 2000. PMID: 11121650

10

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.

Kattan MW, Zelefsky MJ, Kupelian PA, Scardino PT, Fuks Z, Leibel SA. Kattan MW, et al. Among authors: leibel sa. J Clin Oncol. 2000 Oct 1;18(19):3352-9. doi: 10.1200/JCO.2000.18.19.3352. J Clin Oncol. 2000. PMID: 11013275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters